
Avenue Biosciences secured $2.5M for its protein expression engineering platform
Avenue Biosciences has raised $2.5 million in seed funding to develop its machine learning platform that optimizes signal peptides for more efficient protein production, potentially making treatments like monoclonal antibodies and gene therapies more accessible.